CPAI Counterpoint Quantitative Equity ETF

Counterpoint Quantitative Equity ETF (CPAI) currently reports 51 stock positions (subject to change), placing it in the neither concentrated nor index-like range by holdings breadth. The top line-up is PBF (2.88%), TXG (2.55%), FSLY (2.39%), with PBF as the largest single weight at 2.88%. Together, the top three holdings account for 7.82%, which indicates that idiosyncratic risk at the top of the book is relatively contained within the overall portfolio. The resulting profile combines thematic conviction with varying degrees of diversification, which can support upside participation while still spreading idiosyncratic risk beyond the top weights.

From a returns-on-capital standpoint, ROIC is 19.73%, WACC is 9.11%, and the economic spread is 10.62%. On balance, holdings are generating returns that comfortably clear their cost of capital, a reliable indicator of competitive durability. Supporting metrics show ROE at 8.51% and ROA at 6.22%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

The current pricing of the underlying holdings reads trailing P/E of 19.02, forward P/E of 14.89, PEG of 2.82. The small spread between trailing and forward P/E suggests neither meaningful acceleration nor deterioration is currently priced into the earnings outlook. The PEG reading here is above the range most value-oriented investors would find comfortable — the valuation requires a high degree of confidence in forward earnings delivery. The aggregate current ratio of 2.13 points to adequate liquidity across holdings. In aggregate, the valuation reads as fair to moderately stretched — leaving the investment case dependent on earnings execution rather than multiple expansion.

On profitability at each income statement layer, gross margin sits at 34.96%, operating margin at 6.58%, and free cash flow margin at 12.37%. Gross margins are moderate, pointing to holdings where unit economics are functional but not a source of structural advantage. The operating margin reading is modest, consistent with businesses still working to scale their cost structures efficiently. Free cash flow margins are moderate, with a meaningful but not exceptional share of revenue converting to cash after capex. Taken together, the margin stack suggests quality that is uneven — some layers are more resilient than others, and that asymmetry matters under stress.

Looking at what the businesses are actually delivering versus what analysts are pricing in, TTM revenue growth of 28.85% indicating that revenue growth remains a meaningful tailwind for the portfolio. At the same time, the estimated 12-month price change of 22.96%, where implied upside appears constructive but not aggressive. Revenue growth captures operating momentum, while price targets reflect external expectations that can move with rates, risk appetite, and sector sentiment. Whether current momentum translates into delivered returns will depend on the durability of both top-line trends and the assumptions embedded in analyst targets. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The composite of ROIC spread, valuation, revenue momentum, and analyst expectations delivers a rare alignment of quality and growth that justifies elevated conviction.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.